Fluicell AB Logo

Fluicell AB

Developing bioprinted tissues for regenerative medicine and advanced drug screening.

FLUI | ST

Overview

Corporate Details

ISIN(s):
SE0010831321 (+1 more)
LEI:
549300R9LVFVFDTW5Y96
Country:
Sweden
Address:
Flöjelbergsgatan 8c, 431 37 Mölndal
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Fluicell AB is a biotechnology company specializing in single-cell biology and high-precision tissue engineering. The company develops solutions for regenerative medicine and drug screening through its groundbreaking Nexocyte™ platform, which is based on its patented, high-resolution Biopixlar™ single-cell bioprinting technology. Fluicell's primary focus is creating precision-engineered, transplantable tissues to treat diseases with significant unmet needs, with an initial goal to develop a cure for type 1 diabetes. In parallel, the Nexocyte platform generates advanced tissue models for pharmaceutical partners to enhance drug screening, particularly for cardiac and kidney toxicity. The company also commercializes a portfolio of research tools, including the BioPen® and Dynaflow® systems, that support single-cell research globally.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Fluicell AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Fluicell AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
AVACTA GROUP PLC Logo
Developing targeted cancer therapies with a platform that delivers drugs directly to tumors.
United Kingdom AVCT
CAMBRIDGE COGNITION HOLDINGS PLC Logo
Digital brain health assessment platform for CNS clinical trials and research.
United Kingdom COG
Cannabotech Ltd. Logo
Develops botanical medical solutions from cannabinoids & mushrooms for healthcare and wellness.
Israel CNTC
Developing engineered cellular medicines for regenerative treatment of heart failure.
United Kingdom N/A
Ceres Power Holdings PLC Logo
Licensing solid oxide tech (SOFC/SOEC) for clean power and green hydrogen to global partners.
United Kingdom CWR
Combigene AB Logo Sweden COMBI
Cte Group Spolka Akcyjna Logo
Provides B2B services, corporate events, and advanced composite materials R&D.
Poland LPS
Cyxone AB Logo Sweden CYXO
DARWIN AG Logo
AI-powered biotech creating personalized health solutions from biological data for B2C & B2B.
Germany 7V0
DEINOVE Logo France ALDEI

Talk to a Data Expert

Have a question? We'll get back to you promptly.